Koshinski Asset Management Inc. Has $1.37 Million Position in McKesson Co. (NYSE:MCK)

Koshinski Asset Management Inc. increased its holdings in shares of McKesson Co. (NYSE:MCK) by 0.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,404 shares of the company’s stock after buying an additional 22 shares during the period. Koshinski Asset Management Inc.’s holdings in McKesson were worth $1,370,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in MCK. MidAtlantic Capital Management Inc. acquired a new stake in McKesson in the third quarter valued at $29,000. Wolff Wiese Magana LLC increased its stake in shares of McKesson by 742.9% in the third quarter. Wolff Wiese Magana LLC now owns 59 shares of the company’s stock valued at $29,000 after buying an additional 52 shares during the period. RPg Family Wealth Advisory LLC bought a new position in shares of McKesson during the third quarter worth about $31,000. ORG Wealth Partners LLC bought a new stake in McKesson in the third quarter valued at approximately $40,000. Finally, Bruce G. Allen Investments LLC increased its position in McKesson by 51.9% during the 4th quarter. Bruce G. Allen Investments LLC now owns 82 shares of the company’s stock valued at $47,000 after purchasing an additional 28 shares during the period. 85.07% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, EVP Leann B. Smith sold 579 shares of the business’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $572.79, for a total transaction of $331,645.41. Following the transaction, the executive vice president now directly owns 864 shares in the company, valued at approximately $494,890.56. The trade was a 40.12 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.11% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on MCK shares. Citigroup reduced their price objective on shares of McKesson from $713.00 to $677.00 and set a “buy” rating on the stock in a research note on Friday, January 10th. Deutsche Bank Aktiengesellschaft decreased their price target on McKesson from $623.00 to $579.00 and set a “buy” rating for the company in a report on Wednesday, September 25th. StockNews.com raised McKesson from a “hold” rating to a “buy” rating in a research note on Wednesday, November 6th. Leerink Partners decreased their target price on McKesson from $665.00 to $630.00 and set an “outperform” rating for the company in a research note on Monday, October 7th. Finally, Morgan Stanley boosted their price target on McKesson from $612.00 to $642.00 and gave the company an “overweight” rating in a research note on Tuesday, December 17th. Two analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $646.14.

McKesson Price Performance

Shares of NYSE MCK opened at $585.51 on Wednesday. McKesson Co. has a 1 year low of $464.42 and a 1 year high of $637.51. The stock has a market capitalization of $74.32 billion, a P/E ratio of 30.32, a P/E/G ratio of 1.28 and a beta of 0.52. The company has a 50-day moving average price of $594.65 and a 200-day moving average price of $561.08.

McKesson (NYSE:MCK) last released its quarterly earnings results on Wednesday, November 6th. The company reported $7.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.88 by $0.19. McKesson had a negative return on equity of 207.50% and a net margin of 0.77%. The business had revenue of $93.65 billion during the quarter, compared to the consensus estimate of $89.33 billion. During the same quarter in the previous year, the business earned $6.23 EPS. The company’s quarterly revenue was up 21.3% on a year-over-year basis. As a group, equities research analysts anticipate that McKesson Co. will post 32.73 earnings per share for the current fiscal year.

McKesson Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, January 2nd. Shareholders of record on Monday, December 2nd were paid a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a yield of 0.49%. The ex-dividend date was Monday, December 2nd. McKesson’s dividend payout ratio (DPR) is presently 14.71%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.